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Abstract
Background: Neurons and astrocytes are generated from common neural precursors, yet neurogenesis precedes astrocyte
formation during embryogenesis. The mechanisms of neural development underlying suppression and de-suppression of
differentiation- related genes for cell fate specifications are not well understood.
Methodology/Principal Findings: By using an in vitro system in which NTera-2 cells were induced to differentiate into an
astrocyte-like lineage, we revealed a novel role for Sin3A in maintaining the suppression of GFAP in NTera-2 cells. Sin3A
coupled with MeCP2 bound to the GFAP promoter and their occupancies were correlated with repression of GFAP
transcription. The repression by Sin3A and MeCP2 may be an essential mechanism underlying the inhibition of cell
differentiation. Upon commitment toward an astrocyte-like lineage, Sin3A- MeCP2 departed from the promoter and
activated STAT3 simultaneously bound to the promoter and exon 1 of GFAP; meanwhile, olig2 was exported from nuclei to
the cytoplasm. This suggested that a three-dimensional or higher-order structure was provoked by STAT3 binding between
the promoter and proximal coding regions. STAT3 then recruited CBP/p300 to exon 1 and targeted the promoter for histone
H3K9 and H3K14 acetylation. The CBP/p300-mediated histone modification further facilitates chromatin remodeling,
thereby enhancing H3K4 trimethylation and recruitment of RNA polymerase II to activate GFAP gene transcription.
Conclusions/Significance: These results provide evidence that exchange of repressor and activator complexes and
epigenetic modifications are critical strategies for cellular differentiation and lineage-specific gene expression.
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Introduction
During embryonic development, the generation of three major
neural cell types (neurons, astrocytes, and oligodendrocytes) in the
central nervous system (CNS) sequentially occurs, whereby almost
all neurons are generated before the appearance of glial cells [1,2].
Recent findings demonstrated that glial cells are important in
critical neuronal maturation processes such as axonal pathfinding,
synapse formation, neurotransmitter transport, metabolic func-
tions, and the response to CNS injury [3–6]. Although rodent
brain cultures and neuronal and glial cell lines have provided us
with important information about the structure and function of the
mammalian CNS, we have scanty understanding of astrocytic
differentiation.
There has been longstanding interest in understanding how the
process by which progenitors differentiate into different cell types is
regulated. In a mouse model, the fate of progenitors in the
developing brain is believed to be determined by external cues that
involve various types of cytokines and internal cellular programs.
External cues such as bone morphogenetic proteins, leukemia
inhibitoryfactor,ciliaryneurotrophicfactor,Notch-Delta,and basic
fibroblast growth factor promote astrocytic differentiation [7–13],
and most of these factors influence the essential astrogliogenic Janus
kinase-signal transducer and activator of transcription pathway
[14–17]. A molecular basis for the cooperative action between these
families of cytokines involves the formation of a STAT3-Smad1
complex with the coactivator, p300/CBP, that initiates astrocyte-
specific gene expression [15,18–20].
Intrinsic programs regulating cell fate determination of progen-
itors include epigeneticmodifications such as DNAmethylation and
chromatin remodeling. Methylation of the STAT-binding element
within the glial fibrillary acidic protein (GFAP) promoter in mice
was shown to inhibit the association of activated STATs with the
glial promoter, thereby repressing transcription of the GFAP gene
[10,16,21]. Furthermore, conditional deletion of the maintenance
DNA methyltransferase I from neural progenitor cells (NPCs)
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of astrogliogenesis [22]. Another class of epigenetic modifications
was found from FGF2, which regulates the ability of ciliary
neurotrophic factor to enhance astrocyte differentiation by inducing
H3 Lys4 dimethylation and suppressing H3 Lys9 dimethylation at
the STAT3-binding site, resulting in access of the STAT/CBP
complex to the GFAP promoter and activation of GFAP expression
[16]. Those reports highlight the diverse epigenetic mechanisms
that control lineage-specific gene expression; however, it remains
unclear how the interplay among DNA methylation, transcriptional
repressors or activators, and histone modifications contributes to
regulation of the processes.
In this study, we used a human embryonal carcinoma cell line,
NTera-2, to develop a model that induces the differentiation of these
cells into an astrocyte-like lineage. NTera-2 is derived from a human
teratocarcinoma which shares many characteristics of neuroepithelial
precursor cells and is widely used as a tool to study the early
development of the human CNS and identify new genes involved in
neurogenesis [23–25]. We also used this system to investigate the
mechanisms underlying GFAP activation. We identified components
of the Sin3A-HDAC complex coupled with MeCP2 present at the
GFAP promoter under undifferentiated conditions. Upon differen-
tiation, the promoter underwent a conformational change triggered
by STAT3 binding, which contributes to CBP/p300-mediated
histone modification and assembly of a transcription preinitiation
complex, resulting in GFAP gene activation.
Materials and Methods
Cell lines and reagents
NTera-2, 3T3, and 293T cells were obtained from the American
Type Culture Collection (Rockville, MD, USA). Cells were cultured in
Dulbecco’s modified Eagle medium (DMEM; Invitrogen, Durham,
NC, USA) containing 10% fetal bovine serum (FBS; JRH Bioscience,
Lenexa, KS, USA), 0.2 mM GlutaMax-1 (Invitrogen), and penicillin/
streptomycin (100 units/mL; Invitrogen). Cells were split every 2 days
in a 0.5% trypsin-EDTA solution and maintained until used.
Design of the Oct-4 RNAi vector
An oligonucleotide containing a stem-loop structure targeting the
Oct-4 gene was designed using the RNAi program (http://athena.
bioc.uvic.ca/). The targeted sequence was GCGAACCAGTATC-
GAGAAC in the Oct-4/POU5F1 gene (515,534 nt; accession
no. NM_203289). This sequence was first cloned into a pBS/U6
vector. Then the U6-RNAi cassette was subcloned into a lentiviral
vector, pFUGW [26], and the sequences were verified by DNA
sequencing.
Lentiviral production and NTera-2 cell transduction
Lentiviral vectors were produced by transient co-transfection of
pCMVDR8.9 (10 mg), VSV-G (pMD.G; 10 mg), and the lentiviral
vector (pFUGW; 10 mg) into 293T cells. Viral supernatants were
concentrated by ultracentrifugation to produce viruses with titers
of 1610
8 infection units/mL. Multiplicities of infection of 10 and
25 were used to infect NTera-2 cells in the presence of 8 mg/mL
polybrene (Sigma, St. Louis, MO, USA). These transduced cells
expressed green fluorescent protein (GFP) and were analyzed by
fluorescence-activated cell sorting (FACS).
Cell-cycle analysis
Cells were resuspended in PBS and fixed with ethanol overnight
at 220uC. Cells were then resuspended in PBS and treated with
100 mg/ml of ribonuclease A (bovine pancreas; Sigma), 0.1%
Triton-X100, and 40 mg/ml propidium iodide (PI) for 30 min at
37uC. Cell cycles were detected with FACSCalibur, and analyzed
by the ModFit LT program (Verity Software House, Topsham,
ME, USA).
Reverse-transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from NTera-2 cells using the Qiagen
RNeasy Mini kit following the manufacturer’s protocol (Qiagen,
Valencia, CA, USA). The target RNA was amplified by a one-step
RT-PCR kit (GMbiolab, Taichung, Taiwan). Forward and reverse
primers were as follows: GFAP (forward), 59-GTGGGCAGGTGG-
GAGCTTGATTCT-39 and (reverse), 59-CTGGGGCGGCCTGG-
TATGACA-39 [27]; and internal control b-actin (forward), 59-
TGGAATCCTGTGGCATCCATGAAAC-39 and (reverse), 59-
TAAAACGCAGCTCAGTAACAGTCCG-39.T h eR T - P C Rc o n -
sisted of two programs. First was complementary cDNA synthesis: one
cycle at 50uC for 30 min and one cycle at 94uC for 2 min. The other
was second-strand cDNA synthesis and the PCR consisted of 35 cycles
at 94uC for 30 s, 59uCf o r3 0s ,a n d7 2 uC for 45 s; followed by a final
extension step at 72uC for 10 min.
Western blotting
At different times after viral infection, cells were lysed inlysis buffer
(4 M urea, 1 mM MgCl2,5 0m MH E P E S ,a n d1 0 0Ub e n e z o n a s e /
10
7 cells). Lysates containing the equivalent of 2610
5 cells per lane
were separated by electrophoresis on 10% polyacrylamide gels and
electrotransferred onto polyvinylidene difluoride membranes over-
night. The membrane was blocked with 5% fat-free milk in a TBST
solution for 1 h and then probed separatelywith a mouse monoclonal
antibody (mAb) against Oct-4 (Santa-Cruz Biotechnology, Santa
Cruz, CA, USA) at a concentration of 0.2 mg/mL, 1:1000 of an anti-
GFAP rabbit polyclonal antibody (pAb; Chemicon International,
Temecula, CA, USA), and 1:500 of an anti-glutamine synthetase
mouse mAb (Chemicon International). Mouse b-actin was used as an
internal control (Sigma). Horseradish peroxidase (HRP)-conjugated
anti-mouse immunoglobulin G (IgG) and anti-rabbit IgG (Sigma)
were used as the secondary antibodies. Signals were detected using an
enhanced chemiluminescence (ECL) kit (Perkin Elmer, Wellesley,
MA, USA).
Immunoprecipitation
Mock-, vector-, and RNAi-treated cells were solubilized in NP40
lysis buffer (10 mM Tris at pH 7.5, 150 mM NaCl, 0.5% NP40,
5 mM EDTA, 5 mg/ml aprotinine, and 3 mM pAPMSF) and then
centrifuged at 12,000 rpm for 10 min at 4uC. The lysates were
subjected to immunoprecipitation with an anti-STAT3 antibody
(Santa Cruz Biotechnology). Then, these immunocomplexes were
analyzed as described for the Western blot assay. These immunocom-
plexes were detected by an anti-p300 antibody (Santa-Cruz Biotech-
nology).
Immunocytochemistry
NTera-2 cells were grown on 12-well plates. These cells were
washed with phosphate-buffered saline (PBS) and fixed with 3%
paraformaldehyde. Then, cells were permeabilized in 0.25%
Triton X-100 and incubated with the following primary antibodies
overnight at 4uC: anti-Oct-4 rabbit Ab (1:200), anti-Pax6 mouse
Ab (1:50), anti-Olig2 rabbit Ab (1:50; Santa-Cruz Biotechnology),
anti-nestin mouse Ab (1:100), anti-A2B5 mouse Ab (1:200), anti-
glial fibrillary acidic protein rabbit Ab (1:1000), anti-MAP2 rabbit
Ab (1:1000), anti-glutamine synthetase mouse Ab (1:500; Chemi-
con International). The next day, cells were washed with PBS and
secondary antibodies of 1:500 of goat-mouse-594 (Molecular
Probe, Carlsbad, CA, USA), 1:500 of goat-rabbit-cy3, and 1:200
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which were used accordingly for 1 h at 37uC. Cells were then
washed with PBS and counter-stained with Hoechst for 10 min.
Cells were detected under florescence microscopy.
Label-free quantitation method
Preparation of Protein Extracts: Cell pellets were first washed
three times with PBS and lysed in lysis buffer (0.25 M Tris-HCl at
pH 6.8, 1% SDS). Protein concentration was obtained by BCA
TM
protein assay. Cell lysate was then dried and stored in 230uC.
Gel-assisted Digestion [28]: Acrylamide/bisacrylamide (40%,
29:1), 10% APS, and TEMED were then applied to protein
solution to polymerize as a gel directly in the eppendorf. The gel
was cut into small pieces and washed several times with TEABC
containing 50% ACN. The gel samples were further dehydrated
with ACN and the completely dried by vacuum centrifugation.
Proteolytic digestion was then performed with trypsin (protein:
trypsin=50:1, g/g) in 25 mM TEABC with incubation overnight
at 37uC and peptides were extracted by 5% FA in 50% ACN,
dried in a SpeedVac and stored in 230uC.
Immobilized Metal Affinity Chromatography (IMAC) [29]: The
IMAC column was first capping one end with a 0.5 mm frit disk
enclosed instainlesssteelcolumn-end fitting.TheNi-NTAresinwas
extracted from spin column and packed into a 5-cm microcolumn
(500 mm id PEEK column). Automatic purification of phosphopep-
tides was performed using the IMAC microcolumn connected with
autosampler and HP1100 solvent delivery system with a flow rate
13 ml/min. First, the Ni2+ ions were removed with 100 mlE D T A
(50 mM) in NaCl (1 M). Then the IMAC column was activated
with 100 ml FeCl3 (0.2 M) and equilibrated with loading buffer for
30 min before sample loading. For optimization of the phospho-
peptide enrichment, the loading/condition buffer (designated as
loading buffer) was 6% (v/v) AA and the pH was adjusted to 3.0
with NaOH (0.1 M at pH 12.8). The peptide samples from trypsin
digestion were reconstituted in loading buffer and loaded into the
IMAC column that had been equilibrated with the same loading
buffer for 20 min. Then the unbound peptides were removed with
100 ml washing solution consisting of 75% (v/v) loading buffer and
25% (v/v) ACN, followed by equilibration with loading buffer for
15 min. Finally, the bound peptides were eluted from the IMAC
column with 100 ml NH4H2PO4 (200 mM at pH 4.4). Eluted
peptide samples were dried under vacuum and reconstituted in
0.1% (v/v) FA for LC- MS/MS analysis.
LC-MS/MS Analysis: Purified phosphopeptide samples were
reconstituted in 4 ml buffer A (0.1% FA in H2O )a n da n a l y z e db y
LC-Q-TOF MS (Waters Q-TOFTM Premier from Waters Corp). For
LC-MS/MS analysis by Waters Q-TOFTM Premier, samples were
injected into a 2 cm6180 mm capillary trap column and separated by
20 cm675 mm Waters1 ACQUITYTM 1.7 mm BEH C18 column
using a nanoACQUITY Ultra Performance LCTM system (Waters
Corp). The column was maintained at 35uC and eluted with a linear
gradient of 0–80% buffer B (0.1% FA in ACN) for 80, 120, 210 and
270 min. MS was operated in ESI positive V mode with a resolving
power of 10,000. NanoLockSpray source was used for accurate mass
measurement and the lock mass channel was sampled every 30 s. The
mass spectrometer was calibrated with a synthetic human [Glu1]-
Fibrinopeptide B solution (1 pmol/ml; Sigma) delivered through the
NanoLockSpray source. Data acquisition was operated in the data
directed analysis (DDA). The method included a full MS scan (m/z
400–1600, 0.6 s) and 3 MS/MS (m/z 100–1990, 1.2 s each scan)
sequentially on the most three intense ions present in the full scan mass
spectrum.
Database Search, Protein Identification and Quantitation: Raw
data were processed using Mascot Distiller v 2.1.1.0 (Matrix
science). The resulting MS/MS dataset was exported to *mzdata
data file format. We performed the peptide identification and
assignment of partial post-translational modifications using an in-
house version of Mascot v. 2.2 (Matrix science). The datasets were
searched against International Protein Index (IPI_human v. 3.29,
68161 sequences) using the following constraints: only tryptic
peptides with up to two missed cleavage sites were allowed; 0.3-Da
mass tolerances for MS and 0.1-Da mass tolerances for MS/MS
fragment ions. Phosphorylation (STY), oxidation (M) was specified
as variable modifications. Only unique peptide with scores higher
than 25 was confidently assigned. When unique peptides were
identified to multiple members of a protein family, proteins having
the highest sequence coverage were selected from the Mascot
search output result. To evaluate the protein identification false-
positive rate, we repeated the searches using identical search
parameters and validation criteria against a random database
(from the 68161 sequence). Relative quantification of peptides was
performed by IDEAL-Q software [30,31].
DNA methylation analysis
Genomic DNA sodium bisulfite conversion was performed using an
EZ-96 DNA methylation kit (Zymo Research, Orange, CA, USA).
The manufacture’s protocol was followed using 1 mgo fg e n o m i cD N A
and an alternative conversion protocol (two-temperature DNA
denaturation).
Seqqunom’s (San Diego, CA, USA) MassARRAY platform was
used to perform the quantitative methylation analysis. This system
utilizes MALDI-TOF mass spectrometry in combination with
RNA base-specific cleavage (MassCLEAVE kit). A detectable
pattern is then analyzed to determine the methylation status. PCR
primers were designed using EpiDesigner (Sequenom). Amplicons
were designed to cover the CpG sites from an approximately
4500-bp region upstream of the GFAP transcription start site to
the intron 1 region. For each reverse primer, an additional T7
promoter tag for in vivo transcription was added, as well as a 10-
mer tag on the forward primer to adjust for differences in melting
temperatures. The PCRs were carried out in a 5-ml format with
10 ng/ml bisulfite-treated DNA, 0.2 units of HotStart Taq DNA
polymerase (Qiagen), 16 supplied HotStart buffer, and 200 mM
PCR primers. Amplification of the PCR was as follows:
preactivation at 95uC for 15 min, 45 cycles of 95uC denaturation
for 20 s, 56uC annealing for 30 s, and 72uC extension for 30 s,
with a final 72uC incubation for 4 min. Dephosphorylation of
unincorporated dNTPs was performed by adding 1.7 mlo fH 2O
and 0.3 units of shrimp alkaline phosphatase (Sequenom), followed
by incubation at 37uC for 20 min and then at 85uC for 10 min to
deactivate the enzyme. Next, in vivo transcription and RNA
cleavage were achieved by adding 2 ml of the PCR product to 5 ml
of the transcription/cleavage reaction and incubation at 37uC for
3 h. The transcription/cleavage reaction contained 27 units of T7
R&DNA polymerase (EpiCentre, Palmerston North, New Zea-
land), 0.646 of T7 R&DNA polymerase buffer, 0.22 mlT
Cleavage Mix (Sequenom), 3.14 mM DTT, 3.21 mlH 2O, and
0.09 mg/ml RNaseA (Sequenom). Reactions were additionally
diluted with 27 mlo fH 2O and conditioned with 6 mg of CLEAN
Resin (Sequenom) for optimal mass-spectrum analysis. Samples
were then dispensed with the MassARRAY nanodispenser
(Samsung, Irvine, CA, USA) on a 384-well SpectroChip
(Sequenom). Mass spectra were acquired using a MassARRAY
Compact MALDI-TOF (Sequenom), and the methylation ratios
were calculated by comparing the difference in spectra intensity
derived from methylated and non-methylated template DNA by
the Epityper software version 1.0 (Sequenom).
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Genomic DNA (500 ng) was bisulfite converted with the EZ DNA
methylation-Gold kit (D5005; Zymo Research, Orange, CA, USA)
according to the manufacturer’s recommendations. Modified DNA
was amplified with the primers listed in Table S1. The PCRs were
carried out with 25 ng bisulfite-treated DNA, 1 mlo fH o t S t a r tTaq
DNA polymerase (Qiagen), 106 supplied HotStart buffer, 4 mlo f
dNTP (25 mM), and 3 mlo fP C Rp r i m e r s( 5mM). PCR conditions
were 94uC for 15 min, then 40 cycles of 94uC for 30 s, 57uC for 30 s,
and 72uC for 30 s. The PCR products were subjected to purification
using the PCR cleanup kit (28160; Qiagen) following the manufac-
turer’s instructions. The purified PCR products (150 ng) were then
subcloned into a TA cloning vector (50 ng) (pGEM-T Easy vector;
Promega, Madison, WI, USA). Several clones of each sample were
verified by sequencing with the T7 universal primer.
Chromatin immunoprecipitation (ChIP) and quantitative
real-time PCR
ChIP was performed as previously described [32] with some
modifications.Briefly,ChIPassayswerecarriedout on 5610
5NTera-2
and RNAi-treated cells. Cells were harvested by trypsinization,
washed, and resuspended to 2610
6 cells/ml in PBS with 20 mM
sodium butyrate. The protein-DNA complexes were fixed using 1%
formaldehyde for 8 min, and crosslinking fixation was stopped by
adding glycine to a final concentration of 125 mM for 5 min. Cross-
linked cells were washed twice with cold PBS/20 mM butyrate,
resuspended in 100 mlo fl y s i sb u f f e r( 5 0m MT r i s - H C la tp H8 ,
10 mM EDTA, 1% SDS, 1 mM PMSF, and 20 mM sodium butyrate
supplemented with a fresh protease inhibitor cocktail (Sigma) and then
sonicated to an average size of 250 bp by a MISONIX Sonicator 3000
for 30 min (with pulses of 30 s on and 30 s off). We used 5 mgo fa n t i -
Sin3A, 20 mg of anti-MeCP2 (sc-994X and sc-20700X; Santa Cruz
Biotechnology), 5 mg of anti-STAT3 (05-485; Upstate-Millipore, New
York, NY, USA), 5 mgo fa n t i - C B P ,5mg of anti-p300, 20 mgo fa n t i -
polII (sc-369X, sc-585X and sc-899X; Santa Cruz Biotechnology),
5 mgo fa n t i - H 3 K 9 A c ,5mg of anti-H3K14Ac (06-942 and 06-911;
Upstate-Millipore), and 2.5 mg of anti-H3K4me3 (ab8580; Abcam,
Cambridge, MA, USA) for immunoprecipitation, which was per-
formed at 4uC with the indicated antibodies by incubation with Protein
A Dynabeads (Invitrogen) equilibrated with 1 ml RIPA buffer (10 mM
Tris-HCl at pH 7.5, 1 mM EDTA, 0.5 mM EGTA 1% Triton X-
100, 0.1% SDS, 0.1% Na-deoxycholate, and 140 mM NaCl) and
protease inhibitors for 2 h. The immunocomplexes were further
incubated with chromatin at 4uC overnight. The bound fraction was
isolated by Protein A Dynabeads according to the manufacturer’s
instructions, and the immunoprecipitated complexes were eluted by
using 300 ml of elution buffer (20 mM Tris-HCl at pH 7.5, 5 mM
EDTA, 50 mM NaCl and 20 mM sodium butyrate) for 30 min at
65uC then for 10 min at room temperature on a rotator. Chromatin
was eluted from the antibody and de-cross-linked by added of 30 ml
pronase (20 mg/ml) and 1 mlC a C l 2 (1 M) then incubating it at 42uC
for 2 h and 65uC for 6 h. The immunoprecipitated DNA was
recovered by a PCR purification kit (Qiagen) according to the
manufacturer’s instructions, and the purified samples were analyzed by
real-time quantitative PCR using an SYBR Green master mix and a
LightCycler 480 sequence detection system (Roche Applied Science,
Mannheim, Germany). PCR primers were designed using the software
program Primer Express (Roche Applied Science), and the amplifica-
tion primers are listed in Table S2. For each sample, the PCR analysis
was performed in triplicate, and the bound fraction was compared with
1:40 diluted input DNA of 1610
5 cells. The results are reported as the
ratio of immunoprecipitated (IP) DNA to input DNA (IP/input). To
obtain relative occupancy values, the IP/input ratio was further
normalized to the level observed at a control region, h, which was
defined as 1.0. Values of NTera-2 cells were compared to those of
RNAi-treated samples.
Results
Induction of differentiation of NTera-2 cells toward an
astrocyte-like lineage
NTera-2 cells are capable of differentiating into mixtures of
neural and glial cells depending upon the induction conditions
[33–35]. Since NTera-2 cells express high levels of Oct-4 [36,37],
we used a lentiviral vector carrying a short hairpin (sh)RNA
(Fig. 1A) to downregulate Oct-4 expression in order to develop a
new protocol for cell differentiation. Three days after transduction
with the shRNA lentivirus, Oct-4 expression was greatly
diminished (Fig. 1B). As shown in Fig. 1C, the cellular morphology
remained the same as control NTera-2 cells at 3 days. However,
dramatic morphological transformation was observed after 21
days of transduction, and cells had become flattened and enlarged,
and showed a bushy morphology with numerous short and highly
branched processes (Fig. 1C). Such a cell morphology exhibited
characteristics similar to protoplasmic astrocytes, distinct from
‘‘fibrous astrocytes’’ [38]. In addition to these morphological
changes, the reduction in Oct-4 expression by NTera-2 cells was
accompanied by a marked reduction in cell proliferation (Fig.
S1A). The growth potential of NTera-2 cells after transduction was
studied by flow cytometry, and these cells had almost ceased cell
cycling with accumulations of cells in the G0/G1 phase on days 4
and 14 (40.6% and 69.1%, respectively, in Fig. S1B). Thereafter,
these cells remained mostly in the G0/G1 phase (e.g., on day 14)
and underwent significant morphological changes, as described
above. In addition, downregulation of Oct-4 expression often leads
to upregulation of Cdx2 in ES cells [39,40]. In NTera-2 cells,
however, Cdx2 expression was not detected in RNAi- transduced
cells (data not shown), indicating that this cell line may be derived
from cells at a stage of embryogenesis later than the origin of the
ES cell line. In addition, NTera-2 cells normally express the
intermediate filament protein, nestin (Fig. 1C), a marker of
neuroglial progenitor cells. But, the expression of nestin disap-
peared 3 days after transduction (Fig. 1C).
The morphological transformation and cessation of proliferation in
RNAi-transduced cells suggested that NTera-2 cells might undergo a
process of differentiation. To further verify that these changes were
accompanied by differentiation toward an astrocyte-like lineage, cells
were examined for the expression of astrocytic markers. The
intermediate filament protein, GFAP, is considered a cell type-specific
marker for astrocytes. GFAP expression was observed in differentiated
cells examined by immunofluorescence and Western blot assays
(Fig. 1D). Another astrocyte-specific marker, glutamine synthetase (GS)
[41], was also detected by immunofluorescence and Western blot
assays in differentiated cells (Fig. 1E). In addition, we detected neither
the oligodendrocyte markers, A2B5 [42] and Gal-C [43], nor the
neuron-specific markers, MAP-2 and Pax6 [44], after 21 days of
transduction (Fig. S1C). Taken together, these differentiated NTera-2
cells produced by our newly developed protocol had an astrocyte-like
morphology and expressed the astrocyte-specific markers, GFAP and
GS, suggesting differentiation toward an astrocytic lineage. Therefore,
these differentiated cells distinctly differed from previous reports of a
mixture of different neuronal cell types after retinoic acid
induction [35].
Nuclear export of olig2 and STAT3 activation during cell
differentiation
Oligo 2 is a basic HLH transcription factor, and its expression in
the nucleus is required for oligodendrocyte development by
Astrocytic Differentiation in Human NTera-2 Cells
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nucleus [45,46]. To confirm the cellular differentiation of NTera-2
cells, we examined the expression of olig2 and found that olig2 was
expressed in nuclei of undifferentiated NTera-2 cells (Fig. 2A).
During specification for an astrocyte-like lineage, there was a
striking translocation in the distribution of olig2 from nuclei to the
cytoplasm (Fig. 2A). Thus, the translocation of olig2 from nuclei
may suggest activation of STAT3 in nuclei. Therefore, we
analyzed the phosphorylation status of STAT3 and found that
there was significant accumulation of phosphorylated STAT3 in
differentiated cells compared to undifferentiated cells (Fig. 2B).
Furthermore, specific antibodies against STAT3 were found to
Figure 1. Differentiation of NTera-2 cells toward an astrocytic lineage. NTera-2 cells were induced to cellular differentiation by infection with
lentiviruses engineered to express pFUGW-Oct-4-RNAi at a multiplicity of infection of 25. A. Construction map of pFUGW-Oct-4-RNAi. B. Immunofluorescence
(red) and Western blots of Oct4 expression in undifferentiated NTera-2 cells and cells 21 days after differentiation. b-Actin was used as an internal control in
the Western blots. Note the substantial reductioni nO c t - 4e x p r e s s i o na f t e rd i f f e r e n t i a t i o n .C. Phase-contrast micrographs for the morphological analysis
(upper panel) and immunofluorescence staining for nestin expression (lower panel, red) of NTera-2 cells 3 and 21 days after differentiation, respectively.
Magnification 4006. D. Immunofluorescence (red) and Western blots for GFAP expression in undifferentiated NTera-2 cells and NTera-2 cells 21 days after
differentiation. E. Immunofluorescence staining and Western blot analyses of glutamine synthetase (GS) expression in NTera-2 cells 21 days after
differentiation. The red staining for GS was compared with Hoechst dye (blue) for nuclei. b-actin was used as an internal control in the Western blots.
doi:10.1371/journal.pone.0022018.g001
Astrocytic Differentiation in Human NTera-2 Cells
PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22018have co-immunoprecipitated p300 in differentiated cells, but not
in undifferentiated cells, suggesting specific formation of STAT3-
p300 complexes in differentiated cells (Fig. 2C). These findings
suggest activation of the STAT3 signaling pathway during the
differentiation of NTera-2 cells.
Reduction of histone co-repressor complexes during cell
differentiation
In order to investigate the mechanism of suppression and de-
suppression of astrocyte differentiation-related genes in NTera-2
cells, we investigated and quantified differentially phosphorylated
proteins using a newly developed label-free quantitation technol-
ogy platform [30]. Briefly, phosphoproteins were digested in an
optimized gel-assisted digestion and purified by a highly specific
and reproducible automatic IMAC nanotechnology, followed by
LC-MS/MS analysis. The relative quantification method was
performed by software ‘‘IDEAL-Q’’ which was developed by
SEMI alignment approach (Fig. 3A).
Using NTera-2, it was found that the dynamic phosphopro-
teomic profile was observed after induction toward astrocyte
differentiation. We found that there was a slightly increased in the
overall phosphoproteomic profile levels at day 14 after induction
for differentiation. In contrast, the upregulation and downregula-
tion levels of phosphoproteomic profile increased dramatically and
Figure 2. Translocation of olig2, activation of STAT3 signaling and STAT3-p300 complex formation, and loss of Sin3A after
differentiation. A. Immunofluorescence staining for olig2 (red, upper panel), Hoechst dye (blue, middle panel), and merged images (bottom panel)
are shown for undifferentiated control NTera-2 cells and NTera-2 cells 21 days after differentiation. Magnification 4006. B. STAT3 activation was
examined with a specific antibody against phosphorylated STAT3, and total levels of STAT3 in lysates from undifferentiated NTera-2 cells and NTera-2
cells 21 days after differentiation (left panel) were determined. C. Lysates from cells similarly transduced were subjected to immunoprecipitation with
an antibody against STAT3 and then were also probed with an anti-p300-specific antibody (right panel).
doi:10.1371/journal.pone.0022018.g002
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stimulation for 21days, suggesting the dramatic change in
phosphoproteomic pattern.
To gain insight into the putative biological functions of the
identified proteins, differentially phosphorylated proteins were
functionally annotated and classified by using the functional
annotation tool of Database for Annotation, Visualization and
Integrated Discovery (DAVID) [47,48] bioinformatics resources
(http://david.abcc.ncifcrf.gov) on the National Institute of Allergy
and Infectious Disease (NIAID). This software performed a
statistical analysis based on gene ontologies to identify groups
that were significantly overrepresented (enriched) in this filtered
data set. Upon DAVID gene functional classification, there were
two groups of annotated proteins identified that showed
statistically significant enrichment scores; they included phospho-
proteins and those that were posttranslationally modified by
acetylation (Fig. 3B). In addition, these proteins with significant
enrichment scores were separated to nucleus and cytoplasm in
location. And the proteins that function in the nucleus were
remarkably represented by those that control mRNA processing,
chromosome organization, chromatin assembly/disassembly,
DNA packaging, etc, (Fig. 3B).
Among several potential chromatin related functions, we chose
to study epigenetic regulation and chromatin remodeling during
cellular differentiation in more depth. Three important themes
emerge from the shift in the expression of several known,
classifiable proteins (Fig. 3C). First, the data set contains histone
modifying complexes such as Sin3A and SUDS3. Second group of
proteins are the components of chromatin remodeling complexes
including BAZ1B, SMARCC1 and CHD7. They are thought to
regulate chromatin structures using ATPase activity. The third is a
group of chromatin associating proteins, such that RB1, MCM2,
TRIM24, HMGA1 and RCC1. They are involved in diverse
functions such as transcriptional control, DNA replication and
chromosome condensation.
Of particular interest is the significant reduction of Sin3A in the
phosphoproteomic pattern after 3 days of transduction. Sin3A is a
component of Sin3A/HDAC co-repressor complexes, which
functions in transcription repression [49–51], but its role in
astrocyte differentiation has not been characterized. By a Western
blot analysis of samples through the course of differentiation
(control, 7, 14, and 21 days), we further confirmed that the protein
expression of Sin3A decreased significantly and continuously after
differentiation (Fig. 3D). Reduction of the expression of Sin3A
may lead to disintegration of Sin3A/HDAC complexes thus
causing de-suppression of the transcriptional program that favors
astrocyte-like differentiation, such as activation of GFAP.
Locus-specific reduction in Sin3A and MeCP2 occupancy
Since there was a significant reduction in the expression of
Sin3A at the cellular level after cell differentiation in NTera-2
cells, we next investigated regional alterations in chromatin
around the STAT3-binding site at the promoter and transcription
initiation sites of GFAP before and after astrocyte-like differenti-
ation. To ascertain local changes in transcription factor binding,
we performed ChIP assays with specific antibodies against Sin3A
and MeCP2. In addition, the binding of these two co-repressors
was quantitated by a real-time PCR using primers spanning from
the STAT3 binding site at the promoter to exon 1 relative to the
transcription start site of GFAP (primer sets a–g in Fig. 4A). In
addition, a pair of primer, h (Fig. 4A), located between exons 6
and 7 near the end of GFAP gene and remote from the
transcription regulatory region, served as a negative control. It
was found that upon cellular differentiation, the binding of Sin3A
significantly and specifically diminished around the STAT3
binding site about 1500 bp upstream of the GFAP start site in
the promoter region (primer sets a–c in Fig. 4A) (Fig. 4B). In
addition, we also identified that Sin3A occupancy at primer set g
in the vicinity of exon 1 was strongly reduced after cell
differentiation, whereas binding levels of Sin3A across the exon
1 locus (primer sets e and f) were not altered. Since Sin3A lacks an
intrinsic DNA-binding capacity, it must target itself to promoters
via interactions with other DNA-binding or adaptor proteins, such
as MeCP2, a methyl-CpG-binding protein, which was reported to
interact with Sin3A in Xenopus laevis oocytes [52]. To test the
possibility that MeCP2 may target Sin3A to the GFAP promoter,
we performed a ChIP analysis to inspect the binding of MeCP2
around the STAT3-binding site at the GFAP promoter and in the
proximity of exon 1 before and after cell differentiation. As shown
in Fig. 4B, the level of specific binding between MeCP2 and the
STAT3-binding site at the GFAP promoter (primer sets a–c) and
in the proximity of exon 1 (primer sets d–g, except site e) regions of
GFAP in undifferentiated NTera-2 cells was substantially reduced
in differentiated astrocyte-like cells. As the binding patterns for
MeCP2 and Sin3A at the GFAP promoter and exon 1 occurred in
a coordinated manner, these results suggest that MeCP2 may be
responsible for recruiting the Sin3A co-repressor complex to the
area surrounding the GFAP promoter.
MeCP2 is capable of binding to methylated DNA. There is a
possibility that the reduction in MeCP2 occupancy at the GFAP
promoter was triggered by DNA demethylation of the same
region; we therefore examined the DNA methylation status of the
GFAP gene in NTera-2 cells and differentiated astrocyte-like cells.
However, the bisulfite sequencing analysis showed that upon
differentiation toward an astrocyte-like lineage, the CpG dinucle-
otide around the STAT3-binding site at the promoter (primer sets
P1 and P2 in Fig. 4C) and exon 1 (primer sets E1 and E2) was not
demethylated (Fig. 4C). To further confirm these findings, we
performed a quantitative methylation analysis using MALDI-
TOF/MS to examine the mass signal shift of methylated DNA
compared to unmethylated DNA extracted from undifferentiated
NTera-2 cells, differentiated cells, and control human monocytes.
This study confirmed that CpG sites scattered in the approxi-
mately 4500-bp region upstream of the GFAP transcription start
site were stably methylated before and after differentiation
(Fig. 4D). We concluded that the DNA methylation status of the
GFAP promoter and exon 1 remained unchanged during cellular
differentiation. Our results showed that reduced expression of
Sin3A is accompanied by decreased occupancy of Sin3A and
MeCP2 around the STAT3-binding site of the GFAP promoter,
which was not necessarily accompanied by DNA demethylation in
the same region for the induction of GFAP expression. These
results suggest a critical role for Sin3A in regulating GFAP
expression during astrocytic differentiation.
Activation of GFAP expression
The binding of activated STAT3 to a STAT3 recognition
element (21518 to 21510 bp in relation to the transcription start
site) in the mouse GFAP promoter plays a major role in the
transcriptional activation of GFAP [53]. Activation of STAT3 was
also identified in astrocyte-like cells (Fig. 2B), which suggested that
STAT3 may be responsible for GFAP activation. To test this, the
occupancy of activated STAT3 was examined by a ChIP assay,
using similar primer sets a–g as shown in Fig. 4A. As anticipated,
the occupancy of activated STAT3 was more abundant around
the STAT3- binding site at the GFAP promoter (primer sets b and
c, especially primer set b at the STAT3 binding site) in
differentiated cells compared to undifferentiated cells (Fig. 5A).
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exon 1 region of the GFAP gene, we also detected a second peak of
activated STAT3 binding signals (primer sets e–g) in differentiated
cells but not in undifferentiated NTera-2 cells (Fig. 5A). STAT3 is
a sequence-specific DNA-binding protein; in addition to the
binding site at 21500 bp in the promoter (75% identities), we had
identified a second binding site at +250 bp (TTCCTGGAA) at
exon 1 of human GFAP (85% identities), based on a detailed
sequence comparison with mouse GFAP gene. These results argue
that STAT3 may originally target the binding sequence that
resides at the GFAP promoter, but due to the chromatin
configuration between the promoter and exon 1 in differentiated
cells, STAT3 is also cross-linked to chromatin at exon 1.
Alternatively, the occupancy of activated STAT3 may cause a
Figure 3. Phosphoproteomic signature in cellular differentiation revealed by a label-free quantitation strategy. A. Experiment
workflow for quantitation of astrocyte phosphoproteomics. B. Functional annotation chart of the differentially phosphorylated proteins analyzed by
DAVID [47,48]; the highly represented categories are shown. Ontology terms are shown on the y axis; p-values for the significance of enrichment are
graphed along the x axis. C. Analysis of the regulation of genes through label-free quantitation in NTera-2 cells 3, 7, 14 and 21 days during cell
differentiation compared to undifferentiated NTera-2 cells. Data are expressed as log2 of fold change. D. Western blots showing levels of Sin3A
expression in undifferentiated NTera-2 cells and NTera-2 cells 14 and 21 days after differentiation. b-actin was used as an internal control in the
Western blots.
doi:10.1371/journal.pone.0022018.g003
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22018Figure 4. Sin3A and MeCP2 co-occupy the promoter of GFAP before differentiation. A. Schematic illustration of the structure of the
proximal promoter and coding regions of GFAP. Black boxes indicate exons numbered with roman numbers. Lines connecting the exons are introns.
Hatched boxes denote the 59-untranslated region (UTR) and 39-UTR. The start and stop codons are also indicated. qPCR primer pairs amplifying the
STAT3-binding site and exon 1 regions are indicated as alphabetic letters. Region 39 to the CpG island, h, served as a control primer pair. B. ChIP-qPCR
analyses showing quantitative occupancies of Sin3A (left panel) and MeCP2 (right panel) in indicated regions of the GFAP gene in undifferentiated
NTera-2 cells and at 21 days after differentiation. Multiples of enrichment are the relative abundances of the indicated regions over the control region,
h. Error bars represent the means of triplicate values, and the standard deviation of one ChIP-qPCR experiment representative of two is shown. C. The
methylation status of CpG sites within the STAT3 recognition sequence and GFAP gene exon 1 regions in undifferentiated NTera-2 cells and NTera-2
cells 21 days after differentiation was analyzed by bisulfite sequencing. Closed and open circles respectively indicate methylated and unmethylated
CpG sites. D. Assays were performed on genomic DNA isolated from control, healthy individual blood samples. NT-2, undifferentiated NT-2 cells;
astrocyte, astrocyte-like cells differentiated from NT-2 cells. The relative methylation levels of the indicated CpG sites (presented as a black bar) for the
25,000 bp upstream promoter were determined by a T-reverse cleavage reaction and MALDI-TOF/MS assay (Sequenom EpiTYPER platform).
doi:10.1371/journal.pone.0022018.g004
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stereospecific interaction on surfaces around the GFAP promoter
and transcription start site.
To further validate activation of GFAP induced by STAT3
binding, a ChIP analysis was performed to examine the recruitment
of RNA polymerase II. A comparison of undifferentiated NTera-2
cells with differentiated cells revealed increased recruitment of RNA
polymerase IIto the GFAP gene transcriptionstart site (primer sete)
after differentiation, consistent with enhanced transcription
(Fig. 5B). Previous studies suggested that H3 Lys4 trimethylated
(H3K4me3) nucleosomes occur near transcription start sites of
actively transcribed genes. Moreover, several large-scale and
genome-wide analyses revealed that about 91% of all RNA
polymerase II-binding sites are correlated with H3K4me3-binding
sites and were positively correlated with gene expression levels
[54,55]. Using a ChIP assay, we also found that H3K4me3 was
enriched at sites of transcription initiation (primer sets e–g), with
maximal enrichment immediately downstream of the start site
(primersets e and f)andoverlappingthepeakofRNApolymerase II
at the transcription start site (primer set e) in differentiated cells
compared to undifferentiated cells (Fig. 5C). These results suggest a
close correlation among STAT3-mediated chromatin remodeling,
RNA polymerase II recruitment, and GFAP activation.
Figure 2B and 2C show that activated STAT3 was co-
immunoprecipitated with p300. Furthermore, it was reported that
STAT proteins activate transcription by recruiting the transcription
co-activator, CBP/p300 [56,57], and CBP/p300-induced acetyla-
tion on histone tails is coupled with chromatin remodeling, thereby
enhancing target gene expression [58,59]. We next examined
whether the CBP/p300 co-activator was also associated with the
activated GFAP promoter along with an increase in the histone
acetylation level in the same region. Notably, we did not detect a
significant association between CBP/p300 proteins and the
STAT3-binding site at the GFAP promoter (primer sets a–c), as
indicated by the ChIP analyses (Fig. 5D). Conversely, upon cellular
differentiation, robust recruitment of CBP/p300 proteins was
observed in the vicinity of the exon 1 coding region (primer sets
e–g with the CBP antibody and primer sets d, f, and g with the p300
antibody) (Fig. 5D). Since there is no report of DNA-binding ability
of CBP/p300 in these regions, this result suggested that CBP/p300
was brought to the vicinity of exon 1 by transcription factors such as
STAT3 (Fig. 5A) after cell differentiation. We further inspected the
statusofhistoneacetylationbeforeand afterdifferentiationtosurvey
the influence of CBP/p300 deposition on exon 1. ChIP assays were
conducted with specific antibodies against acetyl-H3K9 (H3K9Ac)
and acetyl-H3K14 (H3K14Ac) in undifferentiated NTera-2 cells
and differentiated cells. The results showed that there were
significant increases in active markers of H3K9Ac (primer sets b
and c) and H3K14Ac (primer sets a and b) around the STAT3-
binding site at the GFAP promoter region, particularly the STAT3-
binding site (primer set b), but not in the exon 1 coding region
(Fig. 5E). In addition, in a separate experiment (Liao, CHand Yu, J.
unpublished observation), we found that treatment of NTera-2 cells
with HDAC inhibitors led to an increase in the acetylated H3K9
and H3K14 using specific antibodies and also GFAP gene
expression. Therefore, our results raise the possibility that the
chromatin structure of the GFAP promoter may undergo dramatic
changes in organization during cell differentiation.
Discussion
Reduction of Sin3A during cell differentiation
Astrocytes are the most numerous cells in the CNS that provide
important support to neurons and modulate synaptic activity [60].
In the present study, we developed a new protocol to obtain pure
population of astrocyte-like cells from human NTera-2. We
revealed a novel role for Sin3A which coupled to MeCP2 and
bound to the STAT3-binding site in the GFAP promoter and its
occupancy was inversely correlated with de-suppression of GFAP
transcription. Sin3A is thought to be devoid of intrinsic DNA-
binding capacity, but is able to be recruited by MeCP2 that linked
to methylated DNA with HDAC complex. Such formation of
corepressor complex by chromatin-bound MeCP2 may lead to
local deacetylation of core histones with subsequent transcriptional
silencing [52,61]. Recent reports proposed that another corepres-
sor, N-CoR, controls differentiation of neural stem cells into
astrocytes [62] because the complex containing N-CoR, Sin3A
and HDAC mediated transcriptional repression [63,64]. In fact,
our phosphoproteomic analysis also confirmed the presence of N-
CoR2 in the undifferentiated NTera-2, which declined signifi-
cantly after cell differentiation (data not shown). These results
support transcriptional repression by Sin3A/MeCP2 complex
serving as one of the critical mechanisms underlying the inhibition
of astrocytic differentiation. It seems that MeCP2 with Sin3A
binds to the methylated STAT3-binding site of the GFAP
promoter, thus making the site inaccessible to STAT3. Upon
cellular differentiation, occupancy by MeCP2 and Sin3A was
significantly and specifically diminished at the STAT3-binding site
of the GFAP promoter, suggesting a new regulatory path to trigger
GFAP activation, in addition to the regulation by STAT3.
Conformational change in the GFAP promoter during cell
differentiation
On the other hand, in differentiated cells, activated STAT3,
present at both STAT3-binding sites of the GFAP promoter and
its exon 1 suggests that a conformational change may bridge both
sides of the transcriptional start site during GFAP activation. This
conformational change resulted in subsequent recruitment of
CBP/p300 to the exon 1 coding region but not the promoter in
the ChIP assay. Finally the specific increase of CBP/p300
occupancy at GFAP locus implies that the acetylation by these
histone acetyltransferases play roles for gene activation of GFAP.
Furthermore, CBP/p300 targeted histone H3 acetylation of the
promoter but not exon 1 and induced chromatin remodeling,
thereby enhancing recruitment of RNA polymerase II to activate
GFAP transcription (Fig. 6). In addition, this notion of the change
of the acetylation status accompanied with GFAP expression in
NTera-2 cells was also supported by another independent assay in
which specific HDAC inhibitors were used to increase the
acetylated H3K9 and H3K14 in NTera-2 cells (Liao, CH and
Yu, J., unpublished observation).
Processes that regulate gene transcription are directly under the
influence of genome organization, and intrachromosomal inter-
actions such as chromatin looping were shown to be involved in
promoting transcriptional activation of genes in eukaryotes
[65,66]. Our ChIP experiments showed that activated STAT3
was present both in STAT3-binding sites of the promoter and in
the exon 1 coding region of GFAP gene, and CBP/p300 was
specifically recruited to the exon 1 coding region but not to the
promoter. These findings imply that there are conformational
changes in the GFAP brought about by STAT3 activation.
To investigate whether the interaction between STAT3 and
CBP/p300 can result in the formation of a DNA loop between the
promoter and coding region of GFAP, a 3C (chromosome
conformation capture) assay [67] was performed. We also
combined the 3C with ChIP (using p300 as a ChIP antibody) in
a ChIP-loop assay [68] that presumably allowed us to determine
which genomic sites would interact and how the candidate
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detect direct evidence of DNA looping at the GFAP promoter and
thus conclusions must await further study. Although we had not
yet establish a cause-and-effect relationship between DNA looping
and GFAP gene transcription, our data of STAT3 and CBP/p300
binding suggest the possibility of DNA looping in the region
surrounding the GFAP promoter. Alternatively, it was shown that
during cell differentiation from a pluripotent to a committed state,
there were global changes in the chromatin structure and
interactions of chromatin-binding proteins [69]. Therefore, we
cannot exclude the possibility that intrachromosomal interactions
occurred in other regions where we did not examine in this study
or that interactions between the promoter and coding region of
GFAP may still occur in a more complicated manner [70].
Figure 5. STAT3 occupies both the promoter and exon 1 of GFAP, recruitment of CBP and p300 to exon 1, and changes in histone
acetylation levels at the STAT3-binding site after differentiation. ChIP analyses were performed using anti-STAT3-P (A), RNA polymerase II
(B), and H3K4me3 (C) antibodies and qPCR primer pairs (Fig. 4A) to detect the indicated regions of the GFAP gene in undifferentiated NTera-2 cells
and cells 21 days after differentiation. D. Chromatin samples from undifferentiated NTera-2 cells and cells 21 days after differentiation were
immunoprecipitated with anti-CBP (left panel) and anti-p300 (right panel) antibodies, and enrichment was quantitated by qPCR. E. A ChIP assay was
performed as described in panel D but with active histone modifications, and anti-H3K9Ac (left panel) and anti-H3K14Ac (right panel) antibodies.
Multiples of enrichment are the relative abundances of the indicated DNA fragments over the control fragment, h. Error bars represent the means of
triplicate values, and the standard deviation of one ChIP-qPCR experiment representative of two is shown.
doi:10.1371/journal.pone.0022018.g005
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It is known that binding of activated STAT3 to a consensus site
in the GFAP promoter plays a role in the transcriptional activation
of GFAP [53]. Our observations showed that GFAP expression
was induced during astrocyte-like differentiation of NTera-2. ChIP
experiments confirmed that there was a strong association of
STAT3 with the GFAP promoter, suggesting the existence of
mechanism that facilitates access of the STAT3 complex to the
GFAP promoter. Methylation of CpGs in DNA constitutes one
epigenetic mark that generally correlated with transcriptionally
silent chromatin, and hypomethylated DNA in the promoter is a
hallmark of vertebrate genes that are actively transcribed [71]. In
mouse model, GFAP activation was associated with the loss of
DNA methylation at the STAT3-binding site [22]. However, our
investigation on the epigenetic regulation of GFAP expression in
human NTera-2 cells did not observe changes of DNA
methylation at the promoter (up to 4,500 bp upstream), indicating
that regulation of the interaction of the STAT3 complex in the
GFAP promoter was not mediated by DNA demethylation [21].
There seem to be several explanations that may account for the
discrepancies between our results and previous data from the
mouse study. First, since no enzyme has yet been identified that
actively removes the methyl group from DNA, it is believed that
DNA methylation is passively removed through multiple rounds of
DNA replication [72]. In present study, the differentiated cells
from NTera-2 underwent growth arrest on day 3 after induction.
Therefore, it was not possible for these cells to have reduced the
methylation level of DNA through cell division. Secondly, it was
recently observed that DNA hypermethylation was completely
maintained at the promoter region of the erythroid- specific
carbonic anhydrase II upon hormone-induced activation [73].
Thus this finding challenges the paradigm that the methylation of
promoter-containing CpG islands invariantly causes gene silenc-
ing. Finally, it was reported that parental allele-specific histone
modifications in the promoter, rather than the differentiated
methylated DNA, marked the imprinting status of imprinted genes
[74].
In other word, the promoter-restricted change of histone
modifications is one of the governing epigenetic marks in
transcriptional regulation. Studies in yeast have demonstrated
Figure 6. Model for GFAP gene activation for induced human astrocytic differentiation. In undifferentiated NTera-2 cells, the presence of
the MeCP2 and Sin3A corepressor complex and possibly associated HDAC activity at the GFAP promoter maintain the deacetylated status of
chromatin and repress GFAP transcription. Upon cellular differentiation, MeCP2 and Sin3A became dissociated from the GFAP promoter, and the
subsequent recruitment of the phosphorylated STAT3 caused a conformational change in the region surrounding the GFAP transcription starting site.
This, in turn, facilitated histone H3 acetylation of the promoter resulting from the recruitment of CBP/p300 to exon 1. The combination of chromatin
remodeling and promoter conformational changes enabled the recruitment of RNA pol II.
doi:10.1371/journal.pone.0022018.g006
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actively transcribed genes [75–80]. Similarly, acetylation of
histone H3K9 and H3K14 is critical for the recruitment of
transcription factor II D, an initiation step in transcription, and
therefore be associated with actively transcribed genes [77,79,81–
83]. Histone acetylation is catalyzed by several evolutionarily
conserved histone acetyltransferases, including Gcn5/PCAF,
TAF1, and CBP/p300 [84]. Genome-wide analysis in human
cells confirmed that H3K4me3, H3K9Ac and H3K14Ac are
present together at actively transcribed genes [85]. Our ChIP
experiments showed that upon GFAP activation after cell
differentiation, there were significant increases in active markers
of H3K9Ac and H3K14Ac around the STAT3-binding site at the
GFAP promoter region. At the same time, H3K4me3 was
enriched and overlapped with the peak of RNA polymerase II
at the transcription start site. These results support the notion that
chromatin remodeling regulated by histone modification is linked
to active transcription and provide evidence that the acetylation
status of chromatin at the GFAP promoter is likely to be
predominant regulator of transcription. Altogether, our study
has added a novel regulatory path to GFAP gene expression in
addition to DNA methylation.
Induction of differentiation of NTera-2 cells toward an
astrocyte-like lineage
Human NTera-2 cells are widely used as models in human
neurogenesis and differentiate into mixtures of various neuronal
cell types [35,86]; but directed differentiation toward specific
lineages such as astrocytic cells has not been accomplished. In this
study, we developed an in vitro model of cellular differentiation in
which human NTera-2 cells were differentiated into a homoge-
nous population of cells with an astrocyte-like morphology and
expressing astrocyte-specific, but not neural or oligodendrocyte
markers. The advantages of this model over other in vitro systems
for human astrocyte-like differentiation include its capability for
robust differentiation and the formation of astrocyte-like cells but
not other neuronal cell types. Such directed differentiation differs
from those which induce differentiation into mixtures of mostly
neurons and a few astrocytes after the 4- or 5-week treatment with
retinoic acid [35]. Thus this in vitro human cell model can be used
to examine a detailed mechanism underlying astrocytic differen-
tiation. By now there is strong evidence that astrocyte develop-
ment and regeneration play critical roles in repair after brain
injury and future studies should clarify how these astrocytes are
regenerated and how precursor cells can be manipulated to
recover from brain injuries.
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were similarly induced and then collected, stained with propidium
iodide, and analyzed by flow cytometry. The ratios of cells in the
G0/G1 phase on days 4, 7, and 14 days are shown. C.
Immunofluorescent localization of A2B5, Gal-c, MAP-2, and
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